Presentation at the TD Cowen 45th Annual Healthcare Conference
February 26, 2025
FDA Acceptance of Supplemental New Drug Application for UZEDY® as a Treatment for Patients with Bipolar I Disorder
February 25, 2025
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia
February 10, 2025
Medincell to Join the Euronext SBF 120 Index
December 12, 2024
[Replay] Videoconference – H1 2024-25 Results
December 10, 2024
